Ann: MDR September 2020 Quarterly Report & Appendix 4C, page-2

So a lot going live in 2Q21
1. US - extension to already live program
2. US - HMS integration and secure digital programs with HMS customers
3. Asia - pilot health programs in Phil & Malaysia
4. Asia - first pharmacy customer with white labeled app going live and promotion to patients in 2Q
5. UK - Day Lewis rollout
6. UK - NPA app live in late 2Q

Surely we should see an noticeable uptick in revenues from 1, 3, and then something from 4 & 5 (albeit small).

In addition, they need to highlight how they are monetising ePrescribing....it just seems like there is a lot of functionality being provided to pharmacies, but no material uptick in revenues....I mean over 60% of the pharmacy market & 3m in revenue per quarter seems too cheap IMO. Also the growth in each of these categories need to be in the double digit rather than the overall revenues.....cmon mgmt!